|
GB8923123D0
(en)
|
1989-10-13 |
1989-11-29 |
Connaught Lab |
A vaccine for human immunodeficiency virus
|
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
|
JP3954643B2
(ja)
|
1991-11-16 |
2007-08-08 |
グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム |
マラリア原虫由来のＣＳおよびＨＢｓＡＧ間のハイブリッド蛋白質
|
|
US5580773A
(en)
|
1992-06-17 |
1996-12-03 |
Korea Green Cross Corporation |
Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
|
|
CA2143491C
(en)
|
1994-03-01 |
2011-02-22 |
Yasumasa Ishida |
A novel peptide related to human programmed cell death and dna encoding it
|
|
CA2232669A1
(en)
|
1995-09-27 |
1997-04-03 |
Frances Joanne Morling |
Recombinant viruses incorporating a protease cleavable protein
|
|
AU3289199A
(en)
|
1998-02-11 |
1999-08-30 |
Maxygen, Inc. |
Antigen library immunization
|
|
EP1210428B1
(en)
|
1999-08-23 |
2015-03-18 |
Dana-Farber Cancer Institute, Inc. |
Pd-1, a receptor for b7-4, and uses therefor
|
|
WO2002096939A2
(en)
|
2001-05-30 |
2002-12-05 |
Transgene S.A. |
Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
|
|
ES2350687T3
(es)
|
2002-07-03 |
2011-01-26 |
Ono Pharmaceutical Co., Ltd. |
Composiciones de inmunopotenciación.
|
|
WO2004043399A2
(en)
|
2002-11-13 |
2004-05-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
|
|
US7790181B2
(en)
*
|
2003-05-29 |
2010-09-07 |
The United States Of America As Represented By The Secretary Of The Army |
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
|
|
CA2547511A1
(en)
|
2003-12-01 |
2005-07-28 |
Dow Global Technolgies Inc. |
Recombinant icosahedral virus like particle production in pseudomonads
|
|
MX2007004031A
(es)
|
2004-10-14 |
2007-11-08 |
Crucell Holland Bv |
Vacunas de cebado/refuerzo contra el paludismo.
|
|
JP4819792B2
(ja)
|
2005-02-16 |
2011-11-24 |
国立大学法人東京工業大学 |
改変されたウイルスカプシドタンパク質及びその使用
|
|
MX349137B
(es)
|
2005-06-08 |
2017-07-13 |
Dana-Farber Cancer Inst |
Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1).
|
|
GB0513421D0
(en)
|
2005-06-30 |
2005-08-03 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
CU23586A1
(es)
|
2005-11-22 |
2010-10-30 |
Ct Ingenieria Genetica Biotech |
Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
|
|
EP1997887B1
(en)
|
2006-03-03 |
2013-09-04 |
Ono Pharmaceutical Co., Ltd. |
Multimer of extracellular domain of cell surface functional molecule
|
|
US20100120092A1
(en)
|
2006-08-30 |
2010-05-13 |
Hepgenics Pty Ltd. |
Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same
|
|
WO2009079185A2
(en)
|
2007-11-26 |
2009-06-25 |
Novartis Vaccines And Diagnostics, Inc. |
Methods of generating alphavirus particles
|
|
SG171828A1
(en)
*
|
2008-11-26 |
2011-07-28 |
Us Gov Health & Human Serv |
Virus like particle compositions and methods of use
|
|
EP3718566B1
(en)
*
|
2008-12-09 |
2024-06-12 |
Novavax, Inc. |
Modified rsv f proteins and methods of their use
|
|
CA2774640C
(en)
|
2009-09-18 |
2019-11-26 |
Fraunhofer Usa Inc. |
Virus like particles comprising target proteins fused to plant viral coat proteins
|
|
WO2012006180A1
(en)
|
2010-06-29 |
2012-01-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv immunogens
|
|
WO2012023995A1
(en)
|
2010-08-18 |
2012-02-23 |
Takayuki Shiratsuchi |
Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes
|
|
US9487563B2
(en)
|
2011-01-31 |
2016-11-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Virus-like particles and methods of use
|
|
CN103561771B
(zh)
|
2011-03-17 |
2019-01-04 |
伯明翰大学 |
重新定向的免疫治疗
|
|
AU2012269907B2
(en)
*
|
2011-06-17 |
2017-05-18 |
Bharat Biotech International Limited |
Vaccine composition comprising an inactivated chikungunya virus strain
|
|
CN102321639B
(zh)
|
2011-09-08 |
2013-06-26 |
中国疾病预防控制中心病毒病预防控制所 |
基孔肯雅病毒病毒样颗粒的制备方法和应用
|
|
HK1206366A1
(en)
|
2011-10-25 |
2016-01-08 |
佛罗里达海湾海岸大学理事会 |
Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes
|
|
US9249191B2
(en)
|
2012-02-16 |
2016-02-02 |
Vlp Therapeutics, Llc |
Virus like particle composition
|
|
CN108912215A
(zh)
|
2012-04-02 |
2018-11-30 |
北卡罗来纳-查佩尔山大学 |
用于登革病毒表位的方法和组合物
|
|
CN107540730B
(zh)
|
2012-05-16 |
2021-07-16 |
免疫设计公司 |
用于hsv-2的疫苗
|
|
JP6734651B2
(ja)
|
2013-06-03 |
2020-08-05 |
ブイエルピー・セラピューティクス・リミテッド・ライアビリティ・カンパニーＶＬＰ Ｔｈｅｒａｐｅｕｔｉｃｓ， ＬＬＣ |
マラリアワクチン
|
|
TWI676636B
(zh)
|
2013-07-12 |
2019-11-11 |
Ｖｌｐ醫療股份有限公司 |
包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子
|
|
WO2015139784A1
(en)
|
2014-03-18 |
2015-09-24 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Distinguishing flavivirus infection using a recombinant mutant envelope protein
|
|
US10385101B2
(en)
|
2014-08-08 |
2019-08-20 |
Vlp Therapeutics, Llc |
Virus like particle comprising modified envelope protein E3
|
|
US9969986B2
(en)
|
2014-08-08 |
2018-05-15 |
Vlp Therapeutics, Llc |
Virus like particle comprising modified envelope protein E3
|
|
US9363353B1
(en)
|
2014-12-04 |
2016-06-07 |
Hon Man Ashley Chik |
Mobile phone docks with multiple circulating phone connectors
|
|
AU2015373928B2
(en)
*
|
2014-12-31 |
2019-10-17 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Novel multivalent nanoparticle-based vaccines
|
|
EP3309251A4
(en)
|
2015-06-12 |
2019-03-13 |
Mie University |
HUMAN PARAIN FLUENZA TYPE 2 VIRUS VIRUS VECTOR AND VACCINE
|
|
US10799575B2
(en)
|
2015-06-25 |
2020-10-13 |
Technovax, Inc. |
Flavivirus and alphavirus virus-like particles (VLPS)
|
|
CA2992531C
(en)
|
2015-07-16 |
2023-09-26 |
Bharat Biotech International Limited |
Vaccine compositions
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
CN106085974B
(zh)
|
2016-06-07 |
2019-08-09 |
博奥生物集团有限公司 |
一种寨卡病毒假病毒颗粒及其制备方法
|